NCT06804759进行中（未招募）不适用
A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α to Improve the Signs of Aging
Victoria Collotta2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年11月18日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 40
- 试验地点
- 2
- 主要终点
- Change in appearance of fine lines/wrinkles as evaluated by the Principal Investigator using a scale from 0-9
研究概览
简要总结
A clinical study with approximately 40 subjects, aged 35-65 years of age, who must have crow's feet and at least one other type of facial fine lines/wrinkles in order to evaluate the efficacy of Activated Silk™ 27P-α to improve the signs of aging.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 35 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Healthy individuals, between the ages of 35 - 65 years of age, with no known medical conditions that interfere with study participation, are the priority.
- •Subject has signed a written Informed Consent prior to Day -
- •100% of subjects have crow's feet and at least one of the following: forehead lines/wrinkles (e.g. vertical lines between eyebrows, horizontal lines above the eyebrow), marionette lines, nasolabial folds.
- •50% of subjects have self-perceived sensitive skin.
- •20% of the subjects are not 100% caucasian.
排除标准
- •Subject is pregnant, nursing, or planning to become pregnant.
- •Subject is currently using medication likely to affect the response to investigational formulation.
- •Subject had a fever in the last 12 hours prior to the start of the study.
- •Subject has a pacemaker or significant medical history of hepatic, renal, cardiac, pulmonary, digestive, hematological, neurological, locomotor or psychiatric disease; cancer; multiple sclerosis; high blood pressure; thrombosis; phlebitis (inflammation of a vein); insulin-dependent diabetes; or any such related medical condition(s) that may interfere with the completion of the study.
- •The Subject used a form of retinol on their face in the past six months.
- •The Subject used any prescription skincare products on their face in the last six months.
- •The Subject has received any laser, chemical peel, or other facial resurfacing treatment such as microdermabrasion, dermablading or microneedling in the past four weeks.
- •The Subject received Botox, Dysport, other muscle relaxers or injectable skin fillers in the face during the past six months.
- •Subject has a known allergy or sensitivity to any ingredient in the aqueous skincare formulation provided for their use in the trial .
- •Subject is currently participating in another study utilizing facial products.
- •Subject is blind, visually impaired or decisionally impaired.
结局指标
主要结局
Change in appearance of fine lines/wrinkles as evaluated by the Principal Investigator using a scale from 0-9
时间窗: Day 0 to Day 28
Change in appearance of fine lines/wrinkles for subjects treated with Investigational Facial Serum #1 vs. Investigational Facial Serum #2 at Day 28 vs. Day 0.
次要结局
- Change in appearance of skin characteristics(From Day 0 to Day 28)
研究者
Victoria Collotta
General Manager, Branded Products, Principal Investigator
Evolved By Nature
研究点 (2)
Loading locations...
相似试验
进行中（未招募）
不适用
A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the Signs of Aging, by Comparing to a PlaceboNCT06804772Victoria Collotta15
Unknown
不适用
Treatment With the Profound System for Submental LaxitySubmental LaxityNCT02595216Syneron Medical60
已完成
1 期
Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular DegenerationAge-related MaculopathiesAge-related MaculopathyMaculopathies,Age-relatedMaculopathy,Age-relatedRetinal NeovascularizationEye DiseasesRetinal DegenerationMacular DegenerationNCT01494805Lions Eye Institute, Perth, Western Australia40
已完成
不适用
Clinical Trial to Evaluate the Efficacy and Safety of MegaCarti® in Knee Cartilage DefectsOsteoarthritis, KneeNCT06249828L&C Bio61
Unknown
不适用
Evaluate the Performance of the PicoWayTM Picosecond Fractional Laser for Wrinkles ReductionUnwanted WrinklesNCT02600104Syneron Medical74